Company profile for Stereotaxis

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Stereotaxis is the global leader in innovative robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. Its mission is the discovery, development and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide unsurpassed patient care with robotic precision and safety, expand access to minimall...
Stereotaxis is the global leader in innovative robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. Its mission is the discovery, development and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide unsurpassed patient care with robotic precision and safety, expand access to minimally invasive therapy, and enhance the productivity, connectivity, and intelligence in the operating room.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
710 N Tucker Blvd, Suite 110, St Louis, Missouri 63101,
Telephone
Telephone
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Arvo

Arvo

Not Confirmed

envelop Contact Supplier

Arvo

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2026/04/22/3278874/21634/en/stereotaxis-announces-first-magic-procedures-in-the-united-states.html

GLOBENEWSWIRE
22 Apr 2026

https://www.globenewswire.com/news-release/2026/04/21/3278057/21634/en/stereotaxis-to-report-first-quarter-2026-financial-results-on-may-12-2026.html

GLOBENEWSWIRE
21 Apr 2026

https://www.globenewswire.com/news-release/2026/04/15/3274290/21634/en/Stereotaxis-Announces-Definitive-Agreement-to-Acquire-Robocath.html

GLOBENEWSWIRE
15 Apr 2026

https://www.globenewswire.com/news-release/2026/04/06/3268405/21634/en/Stereotaxis-Announces-FDA-Clearance-and-Launch-of-Synchrony-System.html

GLOBENEWSWIRE
06 Apr 2026

https://www.globenewswire.com/news-release/2026/03/09/3252287/21634/en/Stereotaxis-Reports-2025-Full-Year-Financial-Results.html

GLOBENEWSWIRE
09 Mar 2026

https://www.globenewswire.com/news-release/2026/02/12/3237239/21634/en/Stereotaxis-to-Report-Fourth-Quarter-and-Full-Year-2025-Financial-Results-on-March-9-2026.html

GLOBENEWSWIRE
12 Feb 2026

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty